Natasha van’t Boveneind-Vrubleuskaya

Author

University Medical Center Groningen ORCID

Also Known As

N. van't Boveneind-Vrubleuskaya, N. van‘t Boveneind-Vrubleuskaya, Natasha van't Boveneind-Vrubleuskaya, Natasha van’t Boveneind-Vrubleuskaya

Publications

243

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Westmead Hospital Republican Scientific and Practical Centre of Pulmonology and Tuberculosis GGD Amsterdam

About

Natasha van’t Boveneind-Vrubleuskaya is an author at University Medical Center Groningen specializing in pharmacotherapy, tuberculosis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	46
2	Epidemiology	1	1	29
3	Pharmacology	1	1	17
4	Drug Discovery	1	1	17
5	Drug Resistance	1	1	17

Natasha van’t Boveneind-Vrubleuskaya

Publications

198

Citations

H-Index

Page 1

	Year	Citations
Clinical standards for the dosing and management of TB drugs Jan‐Willem C. Alffenaar, Sophie L. Stocker, Lina Davies Forsman, The International Journal of Tuberculosis and Lung Disease	2022	58
Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients Natasha van’t Boveneind-Vrubleuskaya, Tatiana Seuruk, Kai van Hateren, Antimicrobial Agents and Chemotherapy	2017	33
Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005–2015 Ivan Surya Pradipta, Natasha van’t Boveneind-Vrubleuskaya, Onno W. Akkerman, Antimicrobial Resistance and Infection Control	2019	32
Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study Ivan Surya Pradipta, Natasha van’t Boveneind-Vrubleuskaya, Onno W. Akkerman, Clinical Microbiology and Infection Drug-susceptible TuberculosisPulmonary TuberculosisRetrospective Cohort StudyTreatment And PreventionTuberculosis Prevention	2018	29
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands Fajri Gafar, Natasha van’t Boveneind-Vrubleuskaya, Onno W. Akkerman, European Respiratory Journal	2019	19
Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis Ruben van der Galiën, Natasha van’t Boveneind-Vrubleuskaya, Charles A. Peloquin, Clinical Pharmacokinetics Pharmacokinetic ModelingPharmacologyTuberculosisMultidrug-/extensively Drug-resistant TuberculosisPharmacotherapy	2020	17
Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting Natasha van’t Boveneind-Vrubleuskaya, Alper Daskapan, Jos G. W. Kosterink, PLoS ONE	2016	10

Page 1